Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers.

ABSTRACT: Breast cancer and pancreatic cancer are two common cancer types characterized by high prevalence and high mortality rates, respectively. However, breast cancer has been more well-studied than pancreatic cancer. This narrative review curated inflammation-associated biomarkers from clinical studies that were systematically selected for both breast and pancreatic cancers and discusses some of the common and unique elements between the two endocrine-regulated malignant diseases. Finding common ground between the two cancer types and specifically analyzing breast cancer study results, we hoped to explore potential feasible methods and biomarkers that may be useful also in diagnosing and treating pancreatic cancer. A PubMed MEDLINE search was used to identify articles that were published between

SUBMITTER: Peng J 

PROVIDER: S-EPMC10173309 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature